The Press of Atlantic City
Viva Biotech Awarded 'Top 10 Public Companies'
Jersey Shore
•
Dec 24, 2019
Biotech
Latest New Jersey stories tagged “Biotech”.
The Press of Atlantic City
The Press of Atlantic City
Acucela to Participate in Biotech Showcase 2020
Jersey Shore
•
Dec 23, 2019
The Press of Atlantic City
Third Pole Therapeutics To Present at Biotech Showcase 2020
Jersey Shore
•
Dec 20, 2019
The Press of Atlantic City
Moleculin Announces New Data Shows Reversal of Tumor Activity in Animal Models
Jersey Shore
•
Dec 19, 2019
The Press of Atlantic City
Global & China Bluetooth Speaker Market, 2019-2024: Beckman Coulter, Sony Biotechnology Inc & Luminex Corporation - ResearchAndMarkets.com
Jersey Shore
•
Dec 19, 2019
The Press of Atlantic City
Innovations in Wellness, Biotech, and Digital Health Platforms, 2019 Research Report - ResearchAndMarkets.com
Jersey Shore
•
Dec 18, 2019
The Press of Atlantic City
REGENXBIO Announces Interim Data from Phase I/II Trial of RGX-121 for the Treatment of Mucopolysaccharidosis Type II (MPS II)
Jersey Shore
•
Dec 18, 2019
The Press of Atlantic City
Sengenics, a Leading Commercial Stage Precision Medicine Focused Company, Which Enables Pharma Companies to Identify Drug Responders, to Present at Biotech Showcase...
Jersey Shore
•
Dec 17, 2019
The Press of Atlantic City
Cellestia Biotech AG successfully closes Series B financing round, raising a total of CHF 20 million
Jersey Shore
•
Dec 17, 2019
The Press of Atlantic City
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Jersey Shore
•
Dec 16, 2019
The Press of Atlantic City
GenScript Biotech to Host Global Forum on Cell and Gene Therapy and the Booming China Market During JPM Week
Jersey Shore
•
Dec 16, 2019
The Press of Atlantic City
Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2019...
Jersey Shore
•
Dec 14, 2019
The Press of Atlantic City
Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2019...
Jersey Shore
•
Dec 12, 2019
The Press of Atlantic City
Phoenix Biotechnology Announces Completion of Private Placement
Jersey Shore
•
Dec 11, 2019
The Press of Atlantic City
Panda Biotech Plans the Largest Industrial Hemp Processing Facility for Fiber and Cellulose in the United States
Jersey Shore
•
Dec 10, 2019
The Press of Atlantic City
Incheon City Envisions Biotech Mecca by Developing Songdo Global Biotech Cluster
Jersey Shore
•
Dec 9, 2019
The Press of Atlantic City
Global CRISPR Technology Market Report 2019-2025 with Analysis of Key Companies - Thermo Fisher Scientific, Merck KGaA, GenScript Biotech, Horizon Discovery Group,...
Jersey Shore
•
Dec 5, 2019
The Press of Atlantic City
New AI Biotech Company Zenerchi Announces Partnership with Pop Life Global
Jersey Shore
•
Dec 3, 2019
The Press of Atlantic City
Puma Biotechnology Licensing Partner Specialised Therapeutics Receives Marketing Approval in Singapore for NERLYNX (neratinib) for Extended Adjuvant Treatment...
Jersey Shore
•
Dec 2, 2019
The Press of Atlantic City
Cyrus Biotechnology and the Broad Institute of MIT and Harvard Launch Multi-Target Collaboration to Develop Optimized CRISPR Gene Editing Technology
Jersey Shore
•
Dec 2, 2019
The Republic | New Jersey
Novartis to buy The Medicines Company for $9.7 billion
New Jersey
•
Nov 24, 2019
Daily Mail on New Jersey
Novartis to buy U.S. biotech The Medicines Co. for $9.7 bln
New Jersey Non-Local Sources
•
Nov 24, 2019
Return On Information New Jersey
Hamiton-based Genesis Biotechnology Group acquires NEDP to grow
New Jersey Business
•
Nov 19, 2019
The Press of Atlantic City
InterVenn Biosciences Announces Positive Interim Clinical Trial Results and Appoints Biotech Veteran Klaus Lindpaintner, M.D. as Chief Scientific and Medical Officer
Jersey Shore
•
Nov 18, 2019